Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Murphy

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 27, 2023
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma controlBradley Chipps, Robert S Zeiger, David A Beuther, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 18, 2024
Assessing meaningful change in the Asthma Impairment and Risk QuestionnaireWilliam McCann, Kevin R Murphy, Robert S Zeiger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 23, 2022
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma ExacerbationsDavid A Beuther, Kevin R Murphy, Robert S Zeiger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2026
Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severitiesWilliam A McCann, Bradley E Chipps, David A Beuther, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 5, 2022
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recallBradley E Chipps, Kevin R Murphy, Robert A Wise, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 5, 2024
Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction AbilityKevin R Murphy, David A Beuther, Bradley E Chipps, et al.
Cardiovascular Research|January 19, 2017
SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyRTae Yun Kim, Radmila Terentyeva, Karim H F Roder, et al.
Journal of Asthma and Allergy|January 13, 2023
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment AdherenceJoan Reibman, Bradley E Chipps, Robert S Zeiger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2024
Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control toolMiguel J Lanz, Bradley E Chipps, Robert S Zeiger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2025
Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5-11 YearsKevin R Murphy, Bradley Chipps, Miguel J Lanz, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 27, 2023
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma controlBradley Chipps, Robert S Zeiger, David A Beuther, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 18, 2024
Assessing meaningful change in the Asthma Impairment and Risk QuestionnaireWilliam McCann, Kevin R Murphy, Robert S Zeiger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 23, 2022
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma ExacerbationsDavid A Beuther, Kevin R Murphy, Robert S Zeiger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2026
Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severitiesWilliam A McCann, Bradley E Chipps, David A Beuther, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 5, 2022
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recallBradley E Chipps, Kevin R Murphy, Robert A Wise, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 5, 2024
Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction AbilityKevin R Murphy, David A Beuther, Bradley E Chipps, et al.
Cardiovascular Research|January 19, 2017
SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyRTae Yun Kim, Radmila Terentyeva, Karim H F Roder, et al.
Journal of Asthma and Allergy|January 13, 2023
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment AdherenceJoan Reibman, Bradley E Chipps, Robert S Zeiger, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2024
Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control toolMiguel J Lanz, Bradley E Chipps, Robert S Zeiger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2025
Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5-11 YearsKevin R Murphy, Bradley Chipps, Miguel J Lanz, et al.
Pageof 9